<DOC>
	<DOCNO>NCT01761513</DOCNO>
	<brief_summary>A clinical Study evaluate safety pharmacokinetics/pharmacodynamics ( PK/PD ) YH4808 repeat Oral administration Postprandial state healthy volunteer</brief_summary>
	<brief_title>YH4808 Postprandial PK/PD Study Healthy Subjects</brief_title>
	<detailed_description />
	<mesh_term>Esomeprazole</mesh_term>
	<criteria>1 . Healthy male female age 20 55 body mass index ( BMI ) 18.5 25 kg/m2 2 . Subject congenital , chronic disease disease symptoms medical examination result 3 . Subject show negative reaction UBT ( Urea Breath Test ) 4 . Subject judge eligible principal investigator subinvestigator accord various reason include abnormal test result ( clinical laboratory test , chest Xray test , 12lead ECG etc ) 4 week first IP adminitration 5 . Medically acceptable contraception ( include individual medically unable become pregnant ) use clinical trial 6 . Volunteers sign write informed consent voluntarily , prior procedure , use form approve local Institutional Review Board detail explanation purpose , content , characteristic drug 1 . Subject hypersensitive component contain YH4808 drug 2 . Subject history presence clinically significant disease liver , kidney , gastrointestinal tract , nervous system , respiratory system , endocrine system , blood tumor , cardiovascular , urinary system , mental disorder 3 . Subject history surgical operation disease related gastrointestinal symtem ( e.g . crohn 's disaese , ulcer etc except appendectomy simple herina ) 4 . Other exclusion apply</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>April 2014</verification_date>
</DOC>